Publications by authors named "Anna Elgart"

12Publications

The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator.

Clin Pharmacol Drug Dev 2020 Apr 1. Epub 2020 Apr 1.

Teva Pharmaceutical Industries Ltd, Netanya, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.785DOI Listing
April 2020

Pharmacokinetics and safety of single and multiple doses of rasagiline in healthy Japanese and caucasian subjects.

Basic Clin Pharmacol Toxicol 2019 Mar 21;124(3):273-284. Epub 2018 Oct 21.

Teva Pharmaceuticals Ltd., Netanya, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.13131DOI Listing
March 2019

A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.

Clin Pharmacol Drug Dev 2019 01 22;8(1):49-59. Epub 2018 May 22.

eResearch Technology, Inc, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.442DOI Listing
January 2019

Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.

Pharm Res 2013 Dec 18;30(12):3029-44. Epub 2013 May 18.

Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O.Box 12065, Jerusalem, 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-013-1063-yDOI Listing
December 2013

Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds.

Chem Phys Lipids 2012 May 9;165(4):438-53. Epub 2012 Feb 9.

Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chemphyslip.2012.01.007DOI Listing
May 2012

Cyclosporin pro-dispersion liposphere formulation.

J Control Release 2012 Jun 29;160(2):401-6. Epub 2011 Dec 29.

Department of Medicinal Chemistry, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2011.12.016DOI Listing
June 2012

Antihyperglycaemic activity of 2,4:3,5-dibenzylidene-D-xylose-diethyl dithioacetal in diabetic mice.

J Cell Mol Med 2012 Mar;16(3):594-604

Department of Pharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2011.01340.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822934PMC
March 2012

Polysaccharide pharmacokinetics: amphotericin B arabinogalactan conjugate-a drug delivery system or a new pharmaceutical entity?

Biomacromolecules 2010 Aug;11(8):1972-7

Institute for Drug Research, School of Pharmacy, and Department of Clinical Microbiology and Infectious Diseases, The Hebrew University of Jerusalem-Hadassah Medical Center, P.O. Box 12065, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bm100298rDOI Listing
August 2010

Novel D-xylose derivatives stimulate muscle glucose uptake by activating AMP-activated protein kinase alpha.

J Med Chem 2008 Dec;51(24):8096-108

Department of Pharmacology, School of Pharmacy, Faculty of Medicine, The Hebrew University, 91120 Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm8008713DOI Listing
December 2008